The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer
Open accessAbstract
Background: A substantial number of microRNAs (miRNAs) is subject to epigenetic silencing in cancer. Although epigenetic silencing of tumour suppressor genes is an important feature of cervical cancer, little is known about epigenetic silencing of miRNAs. Since DNA methylation-based silencing of hsa-miR-124 occurs in various human cancers, we studied the frequency and functional effects of hsa-miR-124 methylation in cervical carcinogenesis. Results: Quantitative MSP analysis of all 3 loci encoding the mature hsa-miR-124 (hsa-miR-124-1/-2/-3) showed methylation in cervical cancer cell lines SiHa, CaSki and HeLa as well as in late passages of human papillomavirus (HPV) type 16 or 18 immortalised keratinocytes. Treatment of SiHa cells with a demethylating agent reduced hsa-miR-124 methylation levels and induced hsa-miR-124 expression. In HPV-immortalised keratinocytes increased methylation levels were related to reduced hsa-miR-124 expression and higher mRNA expression of IGFBP7, a potential hsa-miR-124 target gene. Ectopic hsa-miR-124 expression in SiHa and CaSki cells decreased proliferation rates and migratory capacity. Combined hsa-miR-124-1 and/or hsa-miR-124-2 methylation analysis of 139 cervical tissue specimens showed an increasing methylation frequency from 0% in normal tissues up to 93% in cervical carcinomas. Increased methylation levels of hsa-miR-124-1 and hsa-miR-124-2 were significantly correlated with reduced hsa-miR-124 expression in cervical tissue specimens. Combined hsa-miR-124-1 and/or hsa-miR-124-2 methylation analysis of 43 cervical scrapes of high-risk HPV positive women was predictive of underlying high-grade lesions. Conclusions: DNA methylation-based silencing of hsa-miR-124 is functionally involved in cervical carcinogenesis and may provide a valuable marker for improved detection of cervical cancer and its high-grade precursor lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“Recent proteomic studies have shown that a single miRNA can regulate expression of hundreds of targets [17,18].”
BackgroundQuadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Self-citationHuman Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 2×
“Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR: Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.”
BackgroundHuman Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Naucler, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
Pisani, P., Bray, F., & Parkin, D. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.1571 · Cited by 730
Bulkmans, N., Berkhof, J., Rozendaal, L., van Kemenade, F., Boeke, A., Bulk, S., Voorhorst, F., Verheijen, R., van Groningen, K., Boon, M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61450-0 · Cited by 637
Self-citationExploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
Kozaki, K.-I., Imoto, I., Mogi, S., Omura, K., & Inazawa, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5194 · Cited by 613
Furuta, M., Kozaki, K.-I., Tanaka, S., Arii, S., Imoto, I., & Inazawa, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp250 · Cited by 573
Jacobs, M. V., Snijders, P. J., van den Brule, A. J., Helmerhorst, T. J., Meijer, C. J., & Walboomers, J. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.791-795.1997 · Cited by 568
Self-citationvan den Brule, A. J. C., Pol, R., Fransen-Daalmeijer, N., Schouls, L. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.779-787.2002 · Cited by 553
Self-citationPatterns of Known and Novel Small RNAs in Human Cervical Cancer
Lui, W.-O., Pourmand, N., Patterson, B. K., & Fire, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0561 · Cited by 432
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J., & Hu, X. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0511 · Cited by 364
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells
Martinez, I., Gardiner, A. S., Board, K. F., Monzon, F. A., Edwards, R. P., & Khan, S. A. (2008) · Oncogene · doi:10.1038/sj.onc.1210919 · Cited by 340
DNA methylation regulates microRNA expression
Han, L., Witmer, P. D. W., Casey, E., Valle, D., & Sukumar, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.8.4486 · Cited by 332
Altered MicroRNA Expression in Cervical Carcinomas
Lee, J.-W., Choi, C. H., Choi, J.-J., Park, Y.-A., Kim, S.-J., Hwang, S. Y., Kim, W. Y., Kim, T.-J., Lee, J.-H., Kim, B.-G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1231 · Cited by 309
Agirre, X., Vilas-Zornoza, A., Jiménez-Velasco, A., Martin-Subero, J. I., Cordeu, L., Gárate, L., San José-Eneriz, E., Abizanda, G., Rodríguez-Otero, P., Fortes, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4025 · Cited by 302
Ando, T., Yoshida, T., Enomoto, S., Asada, K., Tatematsu, M., Ichinose, M., Sugiyama, T., & Ushijima, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24219 · Cited by 279
Bulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Self-citationNarayan, G., Arias‐Pulido, H., Koul, S., Vargas, H., Zhang, F. F., Villella, J., Schneider, A., Terry, M. B., MANSUKHANI, M. M., & Murty, V. V. V. S. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-24 · Cited by 218
TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia
Steenbergen, R. D. M., Kramer, D., Braakhuis, B. J. M., Stern, P. L., Verheijen, R. H. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh031 · Cited by 203
Self-citationHarden, S., Guo, Z., Epstein, J. I., & Sidransky, D. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000049627.90307.4d · Cited by 148
Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic Leukemia
Román‐Gómez, J., Agirre, X., Jiménez‐Velasco, A., Arqueros, V., Vilas‐Zornoza, A., Rodríguez‐Otero, P., Martin-Subero, I., Gárate, L., Cordeu, L., José‐Eneriz, E. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3441 · Cited by 141
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
Widschwendter, A., Müller, H. M., Fiegl, H., Ivarsson, L., Wiedemair, A., Müller‐Holzner, E., Goebel, G., Marth, C., & Widschwendter, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0825-03 · Cited by 138
MicroRNA‐214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells
Yang, Z., Chen, S., Luan, X., Li, Y., Liu, M., Li, X., Liu, T., & Tang, H. (2009) · IUBMB Life · doi:10.1002/iub.252 · Cited by 133
Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
Henken, F. E., Wilting, S. M., Overmeer, R., van Rietschoten, J. G. I., Nygren, A. O. H., Errami, A., Schouten, J. P., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604055 · Cited by 127
Self-citationSteenbergen, R. D. M., Walboomers, J. M. M., Meijer, C. J. L. M., van der Raaij-Helmer, E. M. H., Parker, J., Chow, L. T., Broker, T. R., & Snijders, P. J. F. (1996) · PubMed · Cited by 122
Self-citationOvermeer, R. M., Henken, F. E., Snijders, P. J. F., Claassen-Kramer, D., Berkhof, J. H., Helmerhorst, T. J. M., Heideman, D. A. M., Wilting, S. M., Murakami, Y., Ito, A., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2367 · Cited by 112
Self-citationSuzuki, H., Igarashi, S., Nojima, M., Maruyama, R., Yamamoto, E., Kai, M., Akashi, H., Watanabe, Y., Yamamoto, H., Sasaki, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp179 · Cited by 107
IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis
Ruan, W., Xu, E., Xu, F., Ma, Y., Deng, H., Huang, Q., Lv, B., Hu, H., Lin, J., Cui, J., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3702 · Cited by 106
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis
Overmeer, R. M., Henken, F. E., Bierkens, M., Wilting, S. M., Timmerman, I., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2009) · The Journal of Pathology · doi:10.1002/path.2598 · Cited by 96
Self-citationInsulin-like Growth Factor Binding Protein 7 Mediates Glioma Cell Growth and Migration
Jiang, W., Xiang, C., Cazacu, S., Brodie, C., & Mikkelsen, T. (2008) · Neoplasia · doi:10.1593/neo.08694 · Cited by 82
Pathology of the Uterine Cervix, Vagina and Vulva
Fu, Y. S. (2002) · Cited by 76
Wilting, S. M., de Wilde, J., Meijer, C. J. L. M., Berkhof, J. H., Yi, Y., van Wieringen, W. N., Braakhuis, B. J. M., Meijer, G. A., Ylstra, B., Snijders, P. J. F., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20590 · Cited by 68
Self-citationPathology of the Uterine Cervix, Vagina and Vulva
More, I. A. R. (1990) · Histopathology · doi:10.1111/j.1365-2559.1990.tb01097.x · Cited by 62
Hirano, S., Ito, N., Takahashi, S., et al. (2004) · PubMed · Cited by 60
Kiviat, N., Hawes, S. E., & Feng, Q. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn038 · Cited by 30
Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History
Harris, T. G., Burk, R. D., Yu, H., MINKOFF, H. L., Massad, L. S., Watts, D. H., Ye, Z., Gange, S. J., Kaplan, R. C., Anastos, K., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0686 · Cited by 23
Vaccination against HPV: indications for women and the impact on the cervical screening programme
Heideman, D. A. M., Snijders, P. J. F., Berkhof, J. H., Verheijen, R. H. M., Helmerhorst, T. J. M., & Meijer, C. J. L. M. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01779.x · Cited by 23
Self-citation
Cited by
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Steenbergen, R. D. M., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3728 · Cited by 386
Self-citationDNA methylation-associated silencing of tumor-suppressor microRNAs in cancer
Lopez-Serra, P., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.354 · Cited by 360
DNA methylation and microRNA dysregulation in cancer
Suzuki, H., Maruyama, R., Yamamoto, E., & Kai, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.007 · Cited by 271
Ledderose, C., Möhnle, P., Limbeck, E., Schütz, S., Weis, F., Rink, J., Briegel, J., & Kreth, S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8ebc · Cited by 130
Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis
Zhang, Y., Chen, J., Xue, Q., Wang, J., Zhao, L., Han, K., Zhang, D., & Hou, L. (2019) · BioMed Research International · doi:10.1155/2019/4015969 · Cited by 32
Metadata
- Authors
- Wilting, S. M., van Boerdonk, R. A., Henken, F. E., Meijer, C. J., Diosdado, B., Meijer, G. A., le Sage, C., Agami, R., Snijders, P. J., & Steenbergen, R. D.
- Venue
- Molecular Cancer
- Published
- 2010-06-26
- Volume
- 9
- Issue
- 1
- Pages
- 167-167
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2023027111
- Cited by
- 258
- References
- 48
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.